TY - JOUR
T1 - Vascular resistance and K(f) in normal and PMA-injured rabbit lungs
T2 - Effects of adenosine
AU - Bradley, J. D.
AU - Zanaboni, P. B.
AU - Dahms, T. E.
AU - Webster, R. O.
PY - 1991
Y1 - 1991
N2 - The effects of adenosine (ADO) on pulmonary vascular resistance (PVR) distribution, vascular compliance (C), and permeability were determined in normal and PMA-injured isolated rabbit lungs perfused with a 1:1 mixture of 6% albumin in Krebs-Henseleit buffer and autologous blood. ADO or vehicle was continuously infused into the reservoir at 1, 4, or 5 μmol/min after a 1-μmol bolus of ADO or vehicle. The capillary filtration coefficient (K(f)) and arterial, venous, and double occlusion pressures were measured at baseline and 30 min after phorbol myristate acetate (PMA; 4 x 10-8 M) or vehicle. Perfusate differential and total leukocyte counts as well as adenine nucleotides, 6-ketoprostaglandin F(1α) (6-keto-PGF(1α)), and thromboxane B2 (TxB2) concentrations were determined at each measurement period. ADO was recovered as hypoxanthine and inosine in the perfusate. ADO alone did not alter PVR, C, K(f), or TxB2 but reduced 6-keto-PGF(1α) levels. PMA induced an increase in K(f) (0.024 ± 0.002 to 0.040 ± 0.006 g · cmH2O-1 · min-1, P < 0.05) that was completely blocked by 4 or 5 μmol/min ADO. PVR increased by 63 ± 11% after PMA, primarily in the arteries and arterial and venous microvessels. The postcapillary resistance increase was blunted by 4 μmol/min ADO; 5 μmol/min ADO prevented the PVR increase in all segments. ADO did not affect the initial adherence of neutrophils in the lung or the PMA-induced 87 ± 2% decrease in circulating leukocytes (>98% lymphocytes) or threefold increase in TxB2 levels. These results suggest that protection by ADO is not mediated by the altering of cyclooxygenase products or by leukocyte adherence.
AB - The effects of adenosine (ADO) on pulmonary vascular resistance (PVR) distribution, vascular compliance (C), and permeability were determined in normal and PMA-injured isolated rabbit lungs perfused with a 1:1 mixture of 6% albumin in Krebs-Henseleit buffer and autologous blood. ADO or vehicle was continuously infused into the reservoir at 1, 4, or 5 μmol/min after a 1-μmol bolus of ADO or vehicle. The capillary filtration coefficient (K(f)) and arterial, venous, and double occlusion pressures were measured at baseline and 30 min after phorbol myristate acetate (PMA; 4 x 10-8 M) or vehicle. Perfusate differential and total leukocyte counts as well as adenine nucleotides, 6-ketoprostaglandin F(1α) (6-keto-PGF(1α)), and thromboxane B2 (TxB2) concentrations were determined at each measurement period. ADO was recovered as hypoxanthine and inosine in the perfusate. ADO alone did not alter PVR, C, K(f), or TxB2 but reduced 6-keto-PGF(1α) levels. PMA induced an increase in K(f) (0.024 ± 0.002 to 0.040 ± 0.006 g · cmH2O-1 · min-1, P < 0.05) that was completely blocked by 4 or 5 μmol/min ADO. PVR increased by 63 ± 11% after PMA, primarily in the arteries and arterial and venous microvessels. The postcapillary resistance increase was blunted by 4 μmol/min ADO; 5 μmol/min ADO prevented the PVR increase in all segments. ADO did not affect the initial adherence of neutrophils in the lung or the PMA-induced 87 ± 2% decrease in circulating leukocytes (>98% lymphocytes) or threefold increase in TxB2 levels. These results suggest that protection by ADO is not mediated by the altering of cyclooxygenase products or by leukocyte adherence.
KW - adenine nucleotides
KW - capillary filtration coefficient
KW - compliance
KW - cyclooxygenase
KW - leukocyte adherence
KW - phorbol myristate acetate
KW - prostaglandins
KW - vascular occlusion pressures
KW - vascular resistance
UR - http://www.scopus.com/inward/record.url?scp=0025925053&partnerID=8YFLogxK
U2 - 10.1152/jappl.1991.71.2.417
DO - 10.1152/jappl.1991.71.2.417
M3 - Article
C2 - 1938712
AN - SCOPUS:0025925053
SN - 0161-7567
VL - 71
SP - 417
EP - 424
JO - Journal of Applied Physiology
JF - Journal of Applied Physiology
IS - 2
ER -